These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


523 related items for PubMed ID: 14963763

  • 41. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
    Calabrese F, Loy M, Lunardi F, Marino D, Aversa SM, Rea F.
    Transpl Infect Dis; 2010 Aug 01; 12(4):342-6. PubMed ID: 20030794
    [Abstract] [Full Text] [Related]

  • 42. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience].
    Franco A, Jiménez L, Sillero C, Trigueros M, González D, Alcaraz E, Olivares J.
    Nefrologia; 2010 Aug 01; 30(6):669-75. PubMed ID: 21113217
    [Abstract] [Full Text] [Related]

  • 43. Duplex realtime PCR method for Epstein-Barr virus and human DNA quantification: its application for post-transplant lymphoproliferative disorders detection.
    Fellner MD, Durand K, Rodriguez M, Irazu L, Alonio V, Picconi MA.
    Braz J Infect Dis; 2014 Aug 01; 18(3):271-80. PubMed ID: 24389276
    [Abstract] [Full Text] [Related]

  • 44. Epidemiology and outcome of chronic high Epstein-Barr viral load carriage in pediatric kidney transplant recipients.
    Yamada M, Nguyen C, Fadakar P, Ganoza A, Humar A, Shapiro R, Michaels MG, Green M.
    Pediatr Transplant; 2018 May 01; 22(3):e13147. PubMed ID: 29411474
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Epstein-Barr virus infection in children with renal transplantation: A single-centre experience.
    You J, Kim M, Lee J, Han DJ, Park YS, Lee JH.
    Nephrology (Carlton); 2018 Nov 01; 23(11):1039-1045. PubMed ID: 28869325
    [Abstract] [Full Text] [Related]

  • 48. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients.
    Scheenstra R, Verschuuren EA, de Haan A, Slooff MJ, The TH, Bijleveld CM, Verkade HJ.
    Transpl Infect Dis; 2004 Mar 01; 6(1):15-22. PubMed ID: 15225222
    [Abstract] [Full Text] [Related]

  • 49. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 01; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 50. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
    Weintraub L, Weiner C, Miloh T, Tomaino J, Joashi U, Benchimol C, Strauchen J, Roth M, Wistinghausen B.
    J Pediatr Hematol Oncol; 2014 Nov 01; 36(8):e481-6. PubMed ID: 24878618
    [Abstract] [Full Text] [Related]

  • 51. Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation.
    Fukushima D, Sato K, Kawagishi N, Ohuchi N, Satomi S.
    Transplantation; 2015 Jan 01; 99(1):114-9. PubMed ID: 24846306
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA, Verschuuren EA, Erasmus ME, Hepkema BG, Veeger NJ, Kallenberg CG, van der Bij W.
    Transplantation; 2007 Feb 27; 83(4):433-8. PubMed ID: 17318076
    [Abstract] [Full Text] [Related]

  • 54. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 27; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 55. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.
    Benden C, Aurora P, Burch M, Cubitt D, Lloyd C, Whitmore P, Neligan SL, Elliott MJ.
    J Heart Lung Transplant; 2005 Dec 27; 24(12):2103-8. PubMed ID: 16364857
    [Abstract] [Full Text] [Related]

  • 56. Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR.
    Yancoski J, Danielian S, Ibañez J, Turconi A, Cuarterolo M, Zelazko M, Niesters Hubert GM.
    J Clin Virol; 2004 Sep 27; 31(1):58-65. PubMed ID: 15288615
    [Abstract] [Full Text] [Related]

  • 57. Relationship between CD8+ T-cell phenotype and function, Epstein-Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study.
    Baudouin V, Dehée A, Pédron-Grossetete B, Ansart-Pirenne H, Haddad E, Maisin A, Loirat C, Sterkers G.
    Transplantation; 2004 Jun 15; 77(11):1706-13. PubMed ID: 15201670
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia.
    Hyun H, Park E, Cho M, Min SI, Ha J, Kang HJ, Shin HY, Ha IS, Cheong HI, Ahn YH, Kang HG.
    J Korean Med Sci; 2019 Aug 05; 34(30):e203. PubMed ID: 31373185
    [Abstract] [Full Text] [Related]

  • 60. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
    Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA.
    Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 27.